Now, for the first time, a new group of drugs called monoclonal antibodies have been shown to slow down the decline in thinking and memory in Alzheimer’s patients, the most common form of dementia.

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...

Dr. Kimberly Doyle from Baylor Scott & White shares valuable tips to ward off cognitive decline and keep your mind sharp as ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

There’s one more unexpected but essential key to brain protection: a sense of purpose. “A very robust predictor of health ...

Researchers from DZNE and Otto von Guericke University Magdeburg have identified individuals with increased risk for dementia ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer’s ...

An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease.

In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...

RESEARCHERS have developed a drug that successfully blocks two major Alzheimer’s disease “hotspots” at once, in a “promising” breakthrough against the brain robbing ...

Developed by international researchers led by British experts, RI-AG03, tackles two 'hotspots' on the protein that leads to ...

Developed by international researchers led by British experts, RI-AG03, tackles two 'hotspots' on the protein that leads to ...